All articles by Jamie Bell

  1. Covid-19 drug studies could highlight speed, flexibility and reduced risk of virtual clinical trials

    The speed, flexibility and strong risk-benefit ratio of virtual clinical trials could all be highlighted in the assessment of potential…
    Read More…

    29 Jun
  2. Covid-19 drug studies could highlight speed, flexibility and reduced risk of virtual clinical trials

    The speed, flexibility and strong risk-benefit ratio of virtual clinical trials could all be highlighted in the assessment of potential…
    Read More…

    29 Jun
  3. A closer look at Regeneron and its efforts to provide the world with a Covid-19 treatment

    Like many firms in the pharmaceutical sector, Regeneron has turned a great deal of attention towards the fight against Covid-19…
    Read More…

    19 Jun
  4. A closer look at Regeneron and its efforts to provide the world with a Covid-19 treatment

    Like many firms in the pharmaceutical sector, Regeneron has turned a great deal of attention towards the fight against Covid-19…
    Read More…

    19 Jun
  5. FibroGen: The company attempting to treat pneumonia in Covid-19 patients

    In its attempt to provide treatments for Covid-19 patients, American biopharma firm FibroGen has chosen to tackle the infection slightly…
    Read More…

    15 Jun
  6. FibroGen: The company attempting to treat pneumonia in Covid-19 patients

    In its attempt to provide treatments for Covid-19 patients, American biopharma firm FibroGen has chosen to tackle the infection slightly…
    Read More…

    15 Jun
  7. Moderna timeline: How the biotech firm has moved alongside pharma giants in Covid-19 vaccine race

    On the vaccine front, American biotech firm Moderna was one of the first companies in the world to react to…
    Read More…

    9 Jun
  8. Moderna timeline: How the biotech firm has moved alongside pharma giants in Covid-19 vaccine race

    On the vaccine front, American biotech firm Moderna was one of the first companies in the world to react to…
    Read More…

    8 Jun
  9. ‘Social responsibility’ may be reason chloroquine trials are continuing despite setbacks

    Social responsibility may be a key reason why researchers are still conducting trials for chloroquine as a Covid-19 treatment despite…
    Read More…

    2 Jun
  10. ‘Social responsibility’ may be reason chloroquine trials are continuing despite setbacks

    Social responsibility may be a key reason why researchers are still conducting trials for chloroquine as a Covid-19 treatment despite…
    Read More…

    2 Jun
Close
Close
Close

Go Top